Sagent Pharmaceuticals Announces The Introduction of Oxaliplatin Injection, USP

By: via Benzinga
Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT) today announced the introduction of Oxaliplatin Injection, USP, an antineoplastic agent, now ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.